Abstract |
|
Authors | S F Slovin, G Ragupathi, S Adluri, G Ungers, K Terry, S Kim, M Spassova, W G Bornmann, M Fazzari, L Dantis, K Olkiewicz, K O Lloyd, P O Livingston, S J Danishefsky, H I Scher |
Journal | Proceedings of the National Academy of Sciences of the United States of America
(Proc Natl Acad Sci U S A)
Vol. 96
Issue 10
Pg. 5710-5
(May 11 1999)
ISSN: 0027-8424 [Print] United States |
PMID | 10318949
(Publication Type: Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibodies
- Biomarkers, Tumor
- Cancer Vaccines
- Immunoglobulin G
- Immunoglobulin M
- Vaccines, Conjugate
- globo H-keyhole limpet hemocyanin QS-21 vaccine
- Complement System Proteins
- Prostate-Specific Antigen
|
Topics |
- Aged
- Antibodies
(blood)
- Biomarkers, Tumor
(blood)
- Cancer Vaccines
(chemical synthesis, chemistry, immunology, therapeutic use)
- Carbohydrate Sequence
- Complement System Proteins
(immunology)
- Cytotoxicity Tests, Immunologic
- Humans
- Immunoglobulin G
(blood)
- Immunoglobulin M
(blood)
- Male
- Middle Aged
- Molecular Sequence Data
- Patient Selection
- Prostate-Specific Antigen
(blood)
- Prostatic Neoplasms
(immunology, prevention & control, therapy)
- Time Factors
- Vaccination
- Vaccines, Conjugate
(chemistry, immunology, therapeutic use)
|